Single KDF1 mutation linked to enamel defects

Researchers in China found that a patient-derived KDF1 mutation can derail enamel formation by disrupting cell adhesion and Hippo-YAP signaling in dental epithelial cells. The findings, published May 21 in International Journal of Oral Science, point to a potential drug target for inherited enamel disorders such as amelogenesis imperfecta.

Why it matters: - A single disease-causing mutation can interfere with how enamel-forming cells mature, helping explain why some inherited enamel disorders damage teeth so early. - The study identifies a signaling pathway that may be drug-responsive, raising the possibility of future treatments for amelogenesis imperfecta and related conditions. - Enamel does not regenerate once damaged, so understanding its development has direct implications for lifelong oral health.

What happened: - A research team led by Prof. Wei Zhao and Prof. Dongsheng Yu at Sun Yat-sen University studied a patient-derived KDF1 mutation, p.R303P, linked to inherited enamel defects. - The findings were published May 21, 2026, in Volume 18 of International Journal of Oral Science. - The team used genetically engineered mice, molecular analyses, imaging and dental epithelial cell experiments to trace how the mutation affects tooth development.

The details: - KDF1 was highly expressed in dental epithelial cells and concentrated near cell-to-cell contact regions, suggesting a role in epithelial organization. - The mutation did not reduce KDF1 production, but it disrupted the protein’s proper membrane localization. - Mice with one mutant KDF1 copy and mice with two mutant copies both developed enamel abnormalities, with the strongest defects in homozygous animals. - Mutant mice showed thinner enamel, lower mineral density, abnormal enamel prism structure and delayed tooth eruption. - Key enamel proteins and enzymes were reduced, including amelogenin, ameloblastin and matrix metalloproteinase 20. - Adhesion molecules needed to hold ameloblasts together were also lower, including E-cadherin and integrin β4. - As adhesion weakened, Hippo pathway control broke down and YAP accumulated in the nucleus. - The altered signaling pushed cells toward proliferation instead of proper ameloblast differentiation. - Prof. Zhao said KDF1 acts as a coordinator linking cell adhesion to signals that decide whether ameloblasts keep dividing or mature to form enamel.

Between the lines: - The study suggests the defect is not just structural; the mutation changes how cells communicate and decide their developmental fate. - That mechanism could matter beyond dentistry, since cell adhesion and Hippo-YAP signaling also help regulate growth in other tissues. - The work points to a broader theme in developmental disease: a mutation can cause harm by rewiring signaling, not only by removing a protein’s basic function.

What's next: - Researchers tested verteporfin, a YAP-TEAD1 inhibitor, to see whether the signaling imbalance could be corrected. - Treated cells showed less proliferation and better differentiation. - Mutant mice showed increased enamel volume after treatment, although mineralization was not fully restored. - Prof. Yu said the results provide a foundation for targeted treatments for hereditary enamel disorders. - The findings may support earlier diagnosis in the short term and could help guide future therapies aimed at preserving or regenerating dental tissue.

The bottom line: - The study links a KDF1 mutation to enamel defects through disrupted cell adhesion and Hippo-YAP signaling, and shows the damage can be partially reversed in preclinical models.